Pharmaceutical Industry Information Portal

HomeWorld Pharma News

World Pharma News

FDA partially suspends study of Curis’ lymphoma drug

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, April 11th announced that the U.S. Food...

Oulu University Hospital has signed a strategic partnership with Philips to become “the smartest hospital in the world”

Royal Philips, a global leader in health technology, and Oulu University Hospital in Finland Apr 11th announced a strategic 10-year partnership agreement to support...

Veru’s new drug COVID-19 reduces deaths by 55% among hospitalized patients in an interim analysis of a phase 3 study

Veru Inc., an oncology biopharmaceutical company, April 11th announced positive efficacy and safety results of Phase 3 COVID-19 clinical trial evaluating oral sabizabulin versus...

Glenmark received approval to conduct clinical trials of its small molecule on patients with solid tumors and Hodgkin’s lymphoma

Glenmark Pharmaceuticals Limited, an innovation-driven, the global pharmaceutical company announced that its subsidiary Glenmark Specialty S.A. (Glenmark) received approval from the Indian drug regulator,...

PRAC finds no causal link between Comirnaty and Spikevax mRNA COVID-19 vaccines and autoimmune hepatitis

The April 4-7, 2022 Pharmacovigilance Risk Assessment Committee (PRAC) meeting noted no link between COVID vaccines and autoimmune hepatitis (AIH). The PRAC has concluded that...

CureVac and GSK contract with German government enabling rapid availability of 80 million mRNA-based vaccine

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and GSK today announced that...
spot_img

Expert Articles

spot_img